Literature DB >> 30760924

Singlet molecular oxygen regulates vascular tone and blood pressure in inflammation.

Christopher P Stanley1, Ghassan J Maghzal1,2, Anita Ayer1,2, Jihan Talib1,2, Andrew M Giltrap3, Sudhir Shengule1, Kathryn Wolhuter1, Yutang Wang4,5,6, Preet Chadha1, Cacang Suarna1, Oleksandra Prysyazhna7,8, Jenna Scotcher7,8, Louise L Dunn1,2, Fernanda M Prado9, Nghi Nguyen10, Jephthah O Odiba10, Jonathan B Baell10,11, Johannes-Peter Stasch12, Yorihiro Yamamoto13, Paolo Di Mascio9, Philip Eaton7,8, Richard J Payne3, Roland Stocker14,15.   

Abstract

Singlet molecular oxygen (1O2) has well-established roles in photosynthetic plants, bacteria and fungi1-3, but not in mammals. Chemically generated 1O2 oxidizes the amino acid tryptophan to precursors of a key metabolite called N-formylkynurenine4, whereas enzymatic oxidation of tryptophan to N-formylkynurenine is catalysed by a family of dioxygenases, including indoleamine 2,3-dioxygenase 15. Under inflammatory conditions, this haem-containing enzyme is expressed in arterial endothelial cells, where it contributes to the regulation of blood pressure6. However, whether indoleamine 2,3-dioxygenase 1 forms 1O2 and whether this contributes to blood pressure control have remained unknown. Here we show that arterial indoleamine 2,3-dioxygenase 1 regulates blood pressure via formation of 1O2. We observed that in the presence of hydrogen peroxide, the enzyme generates 1O2 and that this is associated with the stereoselective oxidation of L-tryptophan to a tricyclic hydroperoxide via a previously unrecognized oxidative activation of the dioxygenase activity. The tryptophan-derived hydroperoxide acts in vivo as a signalling molecule, inducing arterial relaxation and decreasing blood pressure; this activity is dependent on Cys42 of protein kinase G1α. Our findings demonstrate a pathophysiological role for 1O2 in mammals through formation of an amino acid-derived hydroperoxide that regulates vascular tone and blood pressure under inflammatory conditions.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30760924     DOI: 10.1038/s41586-019-0947-3

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  6 in total

1.  Indoleamine 2,3-dioxygenase. Kinetic studies on the binding of superoxide anion and molecular oxygen to enzyme.

Authors:  T Taniguchi; M Sono; F Hirata; O Hayaishi; M Tamura; K Hayashi; T Iizuka; Y Ishimura
Journal:  J Biol Chem       Date:  1979-05-10       Impact factor: 5.157

2.  Indoleamine 2,3-dioxygenase. Potassium superoxide as substrate.

Authors:  T Ohnishi; F Hirata; O Hayaish
Journal:  J Biol Chem       Date:  1977-07-10       Impact factor: 5.157

3.  Indoleamine 2,3-dioxygenase. Purification and some properties.

Authors:  T Shimizu; S Nomiyama; F Hirata; O Hayaishi
Journal:  J Biol Chem       Date:  1978-07-10       Impact factor: 5.157

4.  Studies on indoleamine 2,3-dioxygenase. I. Superoxide anion as substrate.

Authors:  F Hirata; O Hayaishi
Journal:  J Biol Chem       Date:  1975-08-10       Impact factor: 5.157

5.  Arterial Pressure Monitoring in Mice.

Authors:  Xin Zhao; David Ho; Shumin Gao; Chull Hong; Dorothy E Vatner; Stephen F Vatner
Journal:  Curr Protoc Mouse Biol       Date:  2011

6.  Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor.

Authors:  K R Weishaupt; C J Gomer; T J Dougherty
Journal:  Cancer Res       Date:  1976-07       Impact factor: 12.701

  6 in total
  21 in total

1.  Structure-based optimization of type III indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors.

Authors:  Ute F Röhrig; Somi Reddy Majjigapu; Pierre Vogel; Aline Reynaud; Florence Pojer; Nahzli Dilek; Patrick Reichenbach; Kelly Ascenção; Melita Irving; George Coukos; Olivier Michielin; Vincent Zoete
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.756

Review 2.  Unbalanced IDO1/IDO2 Endothelial Expression and Skewed Keynurenine Pathway in the Pathogenesis of COVID-19 and Post-COVID-19 Pneumonia.

Authors:  Marco Chilosi; Claudio Doglioni; Claudia Ravaglia; Guido Martignoni; Gian Luca Salvagno; Giovanni Pizzolo; Vincenzo Bronte; Venerino Poletti
Journal:  Biomedicines       Date:  2022-06-06

Review 3.  The Footprint of Kynurenine Pathway in Cardiovascular Diseases.

Authors:  Moein Ala; Seyed Parsa Eftekhar
Journal:  Int J Tryptophan Res       Date:  2022-06-28

4.  Kynurenine Relaxes Arteries of Normotensive Women and Those With Preeclampsia.

Authors:  Stephanie A Worton; Harry A T Pritchard; Susan L Greenwood; Mariam Alakrawi; Alexander E P Heazell; Mark Wareing; Adam Greenstein; Jenny E Myers
Journal:  Circ Res       Date:  2021-03-03       Impact factor: 17.367

Review 5.  Oxidative Stress: A Unifying Paradigm in Hypertension.

Authors:  Rhian M Touyz; Francisco J Rios; Rhéure Alves-Lopes; Karla B Neves; Livia L Camargo; Augusto C Montezano
Journal:  Can J Cardiol       Date:  2020-02-24       Impact factor: 5.223

6.  PKG1α Cysteine-42 Redox State Controls mTORC1 Activation in Pathological Cardiac Hypertrophy.

Authors:  Christian U Oeing; Taishi Nakamura; Shi Pan; Sumita Mishra; Brittany L Dunkerly-Eyring; Kristen M Kokkonen-Simon; Brian L Lin; Anna Chen; Guangshuo Zhu; Djahida Bedja; Dong Ik Lee; David A Kass; Mark J Ranek
Journal:  Circ Res       Date:  2020-05-12       Impact factor: 17.367

7.  ROS Cocktails as an Adjuvant for Personalized Antitumor Vaccination?

Authors:  Ramona Clemen; Sander Bekeschus
Journal:  Vaccines (Basel)       Date:  2021-05-19

Review 8.  Redox control in the pathophysiology of influenza virus infection.

Authors:  Ker-Kong Chen; Moeko Minakuchi; Kenly Wuputra; Chia-Chen Ku; Jia-Bin Pan; Kung-Kai Kuo; Ying-Chu Lin; Shigeo Saito; Chang-Shen Lin; Kazunari K Yokoyama
Journal:  BMC Microbiol       Date:  2020-07-20       Impact factor: 4.465

9.  The [1,2,4]Triazolo[4,3-a]pyridine as a New Player in the Field of IDO1 Catalytic Holo-Inhibitors.

Authors:  Silvia Fallarini; Irene P Bhela; Silvio Aprile; Enza Torre; Alice Ranza; Elena Orecchini; Eleonora Panfili; Maria T Pallotta; Alberto Massarotti; Marta Serafini; Tracey Pirali
Journal:  ChemMedChem       Date:  2021-08-27       Impact factor: 3.540

10.  An effective inactivant based on singlet oxygen-mediated lipid oxidation implicates a new paradigm for broad-spectrum antivirals.

Authors:  Lei Zeng; Meng-Di Wang; Sheng-Li Ming; Guo-Li Li; Peng-Wei Yu; Yan-Li Qi; Da-Wei Jiang; Guo-Yu Yang; Jiang Wang; Bei-Bei Chu
Journal:  Redox Biol       Date:  2020-06-08       Impact factor: 11.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.